Issue 8, 2013

Synthesis, structure–activity relationships and stereochemical investigations of new tricyclic pyridazinone derivatives as potential STAT3 inhibitors

Abstract

Through a cell-based biological screening, the benzocinnolinone derivative (±)-2c was identified as a promising STAT3 inhibitor. Since SAR studies on a series of compounds structurally related to (±)-2c (1c, 2a–p, 3c, 4c, 6) showed that the latter had the most significant inhibitory activity, we investigated in depth its essential structural features. In particular, enantiomeric separation was performed, and the absolute configuration of the stereoisomers was assigned by theoretical and crystallographic studies. The biological evaluation highlighted that (S)-(−)-2c is twice as potent as (R)-(+)-2c.

Graphical abstract: Synthesis, structure–activity relationships and stereochemical investigations of new tricyclic pyridazinone derivatives as potential STAT3 inhibitors

Supplementary files

Article information

Article type
Concise Article
Submitted
27 Mar 2013
Accepted
19 Jun 2013
First published
21 Jun 2013

Med. Chem. Commun., 2013,4, 1181-1188

Synthesis, structure–activity relationships and stereochemical investigations of new tricyclic pyridazinone derivatives as potential STAT3 inhibitors

D. Masciocchi, A. Gelain, F. Porta, F. Meneghetti, A. Pedretti, G. Celentano, D. Barlocco, L. Legnani, L. Toma, B. Kwon, A. Asai and S. Villa, Med. Chem. Commun., 2013, 4, 1181 DOI: 10.1039/C3MD00095H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements